

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.79373532 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.10703620 |
| 3 | negative regulation of cell killing (GO:0031342) | 6.10703620 |
| 4 | negative thymic T cell selection (GO:0045060) | 5.71090813 |
| 5 | negative T cell selection (GO:0043383) | 5.68522138 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.58330955 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.57551259 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.56824158 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.48308016 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.34702981 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.09588340 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.04772054 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 4.98392894 |
| 14 | positive thymic T cell selection (GO:0045059) | 4.96103780 |
| 15 | positive regulation of B cell differentiation (GO:0045579) | 4.77669532 |
| 16 | B cell receptor signaling pathway (GO:0050853) | 4.64247613 |
| 17 | thymic T cell selection (GO:0045061) | 4.63938591 |
| 18 | positive T cell selection (GO:0043368) | 4.61409481 |
| 19 | T cell selection (GO:0045058) | 4.54191996 |
| 20 | leukocyte aggregation (GO:0070486) | 4.52152865 |
| 21 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.48172516 |
| 22 | regulation of B cell differentiation (GO:0045577) | 4.46465414 |
| 23 | T cell migration (GO:0072678) | 4.45289570 |
| 24 | tolerance induction (GO:0002507) | 4.39766356 |
| 25 | response to interleukin-15 (GO:0070672) | 4.28856106 |
| 26 | cellular response to interleukin-15 (GO:0071350) | 4.07384785 |
| 27 | positive regulation of granulocyte differentiation (GO:0030854) | 4.02496192 |
| 28 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.02444347 |
| 29 | positive regulation by symbiont of host defense response (GO:0052509) | 3.96142435 |
| 30 | modulation by symbiont of host defense response (GO:0052031) | 3.96142435 |
| 31 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.96142435 |
| 32 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.96142435 |
| 33 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.96142435 |
| 34 | modulation by symbiont of host immune response (GO:0052553) | 3.96142435 |
| 35 | negative regulation of T cell mediated immunity (GO:0002710) | 3.92722098 |
| 36 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.86345769 |
| 37 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.71262648 |
| 38 | response to muramyl dipeptide (GO:0032495) | 3.69133672 |
| 39 | detection of bacterium (GO:0016045) | 3.62519453 |
| 40 | immunoglobulin mediated immune response (GO:0016064) | 3.60920720 |
| 41 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.60144888 |
| 42 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.56205682 |
| 43 | Peyers patch development (GO:0048541) | 3.56205682 |
| 44 | detection of other organism (GO:0098543) | 3.55836701 |
| 45 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.54115444 |
| 46 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.51923451 |
| 47 | negative regulation of phagocytosis (GO:0050765) | 3.46822904 |
| 48 | cellular extravasation (GO:0045123) | 3.40852546 |
| 49 | activated T cell proliferation (GO:0050798) | 3.36655398 |
| 50 | neutrophil activation involved in immune response (GO:0002283) | 3.34835112 |
| 51 | B cell homeostasis (GO:0001782) | 3.30301289 |
| 52 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.29290124 |
| 53 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.24310262 |
| 54 | mast cell activation (GO:0045576) | 3.23769113 |
| 55 | T cell receptor signaling pathway (GO:0050852) | 3.23016784 |
| 56 | regulation of T cell tolerance induction (GO:0002664) | 3.22644592 |
| 57 | NIK/NF-kappaB signaling (GO:0038061) | 3.22285932 |
| 58 | T cell homeostasis (GO:0043029) | 3.20836316 |
| 59 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.19426270 |
| 60 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.19426270 |
| 61 | macrophage activation involved in immune response (GO:0002281) | 3.15496088 |
| 62 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.14528110 |
| 63 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.14412538 |
| 64 | response to peptidoglycan (GO:0032494) | 3.13127224 |
| 65 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.13037506 |
| 66 | cellular response to type I interferon (GO:0071357) | 3.12881616 |
| 67 | type I interferon signaling pathway (GO:0060337) | 3.12881616 |
| 68 | response to type I interferon (GO:0034340) | 3.12282905 |
| 69 | regulation of granulocyte differentiation (GO:0030852) | 3.11377452 |
| 70 | lymphocyte homeostasis (GO:0002260) | 3.10774783 |
| 71 | positive regulation of interleukin-2 production (GO:0032743) | 3.05413001 |
| 72 | regulation of tolerance induction (GO:0002643) | 3.03238934 |
| 73 | negative regulation of innate immune response (GO:0045824) | 3.02861742 |
| 74 | T cell costimulation (GO:0031295) | 3.00542474 |
| 75 | myeloid cell activation involved in immune response (GO:0002275) | 3.00089933 |
| 76 | B cell mediated immunity (GO:0019724) | 3.00016800 |
| 77 | natural killer cell differentiation (GO:0001779) | 2.99918945 |
| 78 | interferon-gamma production (GO:0032609) | 2.99104767 |
| 79 | regulation of alpha-beta T cell activation (GO:0046634) | 2.97336780 |
| 80 | negative regulation of interleukin-12 production (GO:0032695) | 2.96649101 |
| 81 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.96364623 |
| 82 | lymphocyte costimulation (GO:0031294) | 2.96190151 |
| 83 | positive regulation of isotype switching (GO:0045830) | 2.95987405 |
| 84 | germinal center formation (GO:0002467) | 2.94772394 |
| 85 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.93497119 |
| 86 | regulation of regulatory T cell differentiation (GO:0045589) | 2.91898936 |
| 87 | respiratory burst (GO:0045730) | 2.91006380 |
| 88 | defense response to protozoan (GO:0042832) | 2.90346269 |
| 89 | positive regulation of B cell activation (GO:0050871) | 2.88509050 |
| 90 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.88193398 |
| 91 | neutrophil activation (GO:0042119) | 2.87270114 |
| 92 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.85602274 |
| 93 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.84711399 |
| 94 | leukocyte degranulation (GO:0043299) | 2.84414922 |
| 95 | leukocyte homeostasis (GO:0001776) | 2.82183511 |
| 96 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.82028747 |
| 97 | mast cell activation involved in immune response (GO:0002279) | 2.81825700 |
| 98 | mast cell degranulation (GO:0043303) | 2.81825700 |
| 99 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.79634072 |
| 100 | response to protozoan (GO:0001562) | 2.79506884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.72968174 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.98953221 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.45799520 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.67417668 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.48423249 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.39848656 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.19546770 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.19255871 |
| 9 | MYB_26560356_Chip-Seq_TH2_Human | 3.15698817 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.11187213 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.00088827 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.93385826 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.92919475 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 2.82940776 |
| 15 | MYB_26560356_Chip-Seq_TH1_Human | 2.67655753 |
| 16 | UTX_26944678_Chip-Seq_JUKART_Human | 2.67197207 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.66941695 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.66730408 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.66306647 |
| 20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.64143331 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.59727953 |
| 22 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.57787448 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.51840495 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.50138256 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.48841168 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.44364116 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.41516344 |
| 28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.29606627 |
| 29 | MAF_26560356_Chip-Seq_TH2_Human | 2.26476522 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23579231 |
| 31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.17822403 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.12952609 |
| 33 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.12831208 |
| 34 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.09864716 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.05211557 |
| 36 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.97778920 |
| 37 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.97335025 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.93814818 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.91954888 |
| 40 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.88629303 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85564762 |
| 42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.85508479 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.83414612 |
| 44 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.76611481 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.75737299 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70387454 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68586669 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67975810 |
| 49 | GATA3_26560356_Chip-Seq_TH2_Human | 1.52098039 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51221274 |
| 51 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51118648 |
| 52 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.50786095 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49669005 |
| 54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49482321 |
| 55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45893939 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42026852 |
| 57 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40301918 |
| 58 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.39284491 |
| 59 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37276515 |
| 60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27237957 |
| 61 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.24473279 |
| 62 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.23041090 |
| 63 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21796167 |
| 64 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.21701550 |
| 65 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21674227 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19066496 |
| 67 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.18147375 |
| 68 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17424484 |
| 69 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16680359 |
| 70 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12950786 |
| 71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12941709 |
| 72 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11470259 |
| 73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10913021 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07358618 |
| 75 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06637756 |
| 76 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.05706028 |
| 77 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05061206 |
| 78 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.04893445 |
| 79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03039896 |
| 80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02407243 |
| 81 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01203663 |
| 82 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01149527 |
| 83 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00950922 |
| 84 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99215720 |
| 85 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98868248 |
| 86 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94535654 |
| 87 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94437381 |
| 88 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94227761 |
| 89 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.93212691 |
| 90 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93201017 |
| 91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93195924 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88129667 |
| 93 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.86139871 |
| 94 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.85574874 |
| 95 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.85121962 |
| 96 | P300_27268052_Chip-Seq_Bcells_Human | 0.82642124 |
| 97 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.81801839 |
| 98 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.79983682 |
| 99 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.78714569 |
| 100 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.76916310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.23505997 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.97332927 |
| 3 | MP0005671_abnormal_response_to | 3.82701827 |
| 4 | MP0003436_decreased_susceptibility_to | 3.78418494 |
| 5 | MP0001800_abnormal_humoral_immune | 3.49118689 |
| 6 | MP0000685_abnormal_immune_system | 3.33228094 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.19346368 |
| 8 | MP0003724_increased_susceptibility_to | 3.01330819 |
| 9 | MP0001790_abnormal_immune_system | 2.98366256 |
| 10 | MP0005387_immune_system_phenotype | 2.98366256 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.84246895 |
| 12 | MP0002723_abnormal_immune_serum | 2.83896414 |
| 13 | MP0001819_abnormal_immune_cell | 2.79474595 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.76173572 |
| 15 | MP0003303_peritoneal_inflammation | 2.71009701 |
| 16 | MP0005025_abnormal_response_to | 2.68587454 |
| 17 | MP0002419_abnormal_innate_immunity | 2.58191595 |
| 18 | MP0002398_abnormal_bone_marrow | 2.57416725 |
| 19 | MP0002396_abnormal_hematopoietic_system | 2.47964327 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 2.40277785 |
| 21 | MP0000716_abnormal_immune_system | 2.33760445 |
| 22 | MP0009785_altered_susceptibility_to | 2.31368525 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.29121933 |
| 24 | MP0002405_respiratory_system_inflammati | 2.24884199 |
| 25 | MP0000703_abnormal_thymus_morphology | 2.24800478 |
| 26 | MP0001873_stomach_inflammation | 2.21599041 |
| 27 | MP0000689_abnormal_spleen_morphology | 2.17205394 |
| 28 | MP0006082_CNS_inflammation | 2.14413340 |
| 29 | MP0002722_abnormal_immune_system | 2.11646546 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 2.10012913 |
| 31 | MP0000465_gastrointestinal_hemorrhage | 2.05912567 |
| 32 | MP0005464_abnormal_platelet_physiology | 2.04350239 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.94797262 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.90449252 |
| 35 | MP0002429_abnormal_blood_cell | 1.89447691 |
| 36 | MP0003866_abnormal_defecation | 1.82076771 |
| 37 | MP0004947_skin_inflammation | 1.80404833 |
| 38 | MP0009278_abnormal_bone_marrow | 1.77843398 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.70842216 |
| 40 | MP0002009_preneoplasia | 1.70485411 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.58452374 |
| 42 | MP0004381_abnormal_hair_follicle | 1.53876320 |
| 43 | MP0005310_abnormal_salivary_gland | 1.46751801 |
| 44 | MP0001851_eye_inflammation | 1.46678921 |
| 45 | MP0005075_abnormal_melanosome_morpholog | 1.45133719 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.44370241 |
| 47 | MP0008469_abnormal_protein_level | 1.29020167 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.25584024 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.25584024 |
| 50 | MP0002006_tumorigenesis | 1.22830895 |
| 51 | MP0002132_abnormal_respiratory_system | 1.22696736 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.20959500 |
| 53 | MP0002933_joint_inflammation | 1.19841157 |
| 54 | MP0001853_heart_inflammation | 1.19733601 |
| 55 | MP0000858_altered_metastatic_potential | 1.16051382 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.14625544 |
| 57 | MP0008260_abnormal_autophagy | 1.09417471 |
| 58 | MP0000490_abnormal_crypts_of | 1.00418080 |
| 59 | MP0003191_abnormal_cellular_cholesterol | 0.99729645 |
| 60 | MP0001986_abnormal_taste_sensitivity | 0.98773381 |
| 61 | MP0002019_abnormal_tumor_incidence | 0.98552683 |
| 62 | MP0003828_pulmonary_edema | 0.98479670 |
| 63 | MP0008057_abnormal_DNA_replication | 0.94655626 |
| 64 | MP0005451_abnormal_body_composition | 0.94588671 |
| 65 | MP0009764_decreased_sensitivity_to | 0.93490374 |
| 66 | MP0002998_abnormal_bone_remodeling | 0.91617784 |
| 67 | MP0003183_abnormal_peptide_metabolism | 0.86116246 |
| 68 | MP0001663_abnormal_digestive_system | 0.85996297 |
| 69 | MP0009763_increased_sensitivity_to | 0.77516034 |
| 70 | MP0000015_abnormal_ear_pigmentation | 0.76509666 |
| 71 | MP0004883_abnormal_blood_vessel | 0.75264487 |
| 72 | MP0004130_abnormal_muscle_cell | 0.75197655 |
| 73 | MP0002277_abnormal_respiratory_mucosa | 0.74709812 |
| 74 | MP0001348_abnormal_lacrimal_gland | 0.70634434 |
| 75 | MP0008961_abnormal_basal_metabolism | 0.67036923 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 0.65367363 |
| 77 | MP0005058_abnormal_lysosome_morphology | 0.64576319 |
| 78 | MP0004510_myositis | 0.63808939 |
| 79 | MP0005166_decreased_susceptibility_to | 0.61772530 |
| 80 | MP0009765_abnormal_xenobiotic_induced | 0.61500962 |
| 81 | MP0002693_abnormal_pancreas_physiology | 0.60745108 |
| 82 | MP0003448_altered_tumor_morphology | 0.58574695 |
| 83 | MP0000249_abnormal_blood_vessel | 0.57804931 |
| 84 | MP0005390_skeleton_phenotype | 0.55278782 |
| 85 | MP0009115_abnormal_fat_cell | 0.53159619 |
| 86 | MP0003795_abnormal_bone_structure | 0.49802935 |
| 87 | MP0000604_amyloidosis | 0.49590996 |
| 88 | MP0003690_abnormal_glial_cell | 0.49120433 |
| 89 | MP0003075_altered_response_to | 0.47588917 |
| 90 | MP0003045_fibrosis | 0.47459786 |
| 91 | MP0000609_abnormal_liver_physiology | 0.47241551 |
| 92 | MP0005164_abnormal_response_to | 0.46877145 |
| 93 | MP0008874_decreased_physiological_sensi | 0.45970885 |
| 94 | MP0002163_abnormal_gland_morphology | 0.43826945 |
| 95 | MP0003786_premature_aging | 0.43430403 |
| 96 | MP0005381_digestive/alimentary_phenotyp | 0.42873214 |
| 97 | MP0000313_abnormal_cell_death | 0.42074205 |
| 98 | MP0008873_increased_physiological_sensi | 0.41373649 |
| 99 | MP0002083_premature_death | 0.39795446 |
| 100 | MP0005334_abnormal_fat_pad | 0.39626319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.35800023 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.18730274 |
| 3 | Agammaglobulinemia (HP:0004432) | 4.79090420 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.71291694 |
| 5 | Stomatitis (HP:0010280) | 4.65491135 |
| 6 | Abnormality of T cell number (HP:0011839) | 4.59092534 |
| 7 | Panhypogammaglobulinemia (HP:0003139) | 4.56295824 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 4.52607718 |
| 9 | Recurrent abscess formation (HP:0002722) | 4.52092573 |
| 10 | Recurrent fungal infections (HP:0002841) | 4.48399250 |
| 11 | Meningitis (HP:0001287) | 4.48256808 |
| 12 | T lymphocytopenia (HP:0005403) | 4.35981486 |
| 13 | Myositis (HP:0100614) | 4.29151590 |
| 14 | Autoimmune hemolytic anemia (HP:0001890) | 4.19362244 |
| 15 | Abnormality of T cells (HP:0002843) | 4.10778180 |
| 16 | Recurrent viral infections (HP:0004429) | 4.03800592 |
| 17 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.01651398 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 4.01651398 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 3.88684324 |
| 20 | Increased IgM level (HP:0003496) | 3.84752872 |
| 21 | Granulocytopenia (HP:0001913) | 3.83312932 |
| 22 | Vasculitis (HP:0002633) | 3.82818409 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.74404283 |
| 24 | Abnormality of T cell physiology (HP:0011840) | 3.72913272 |
| 25 | Encephalitis (HP:0002383) | 3.70050294 |
| 26 | Increased IgE level (HP:0003212) | 3.62926636 |
| 27 | Severe combined immunodeficiency (HP:0004430) | 3.58956445 |
| 28 | Autoimmune thrombocytopenia (HP:0001973) | 3.57828398 |
| 29 | Cellulitis (HP:0100658) | 3.55541361 |
| 30 | Recurrent skin infections (HP:0001581) | 3.51801032 |
| 31 | Pustule (HP:0200039) | 3.50500203 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 3.50433479 |
| 33 | Obstructive lung disease (HP:0006536) | 3.50433479 |
| 34 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.48275202 |
| 35 | IgM deficiency (HP:0002850) | 3.45500441 |
| 36 | Lymphopenia (HP:0001888) | 3.45298525 |
| 37 | Orchitis (HP:0100796) | 3.42372134 |
| 38 | Optic neuritis (HP:0100653) | 3.42254959 |
| 39 | Retrobulbar optic neuritis (HP:0100654) | 3.42254959 |
| 40 | Eosinophilia (HP:0001880) | 3.40759689 |
| 41 | Inflammation of the large intestine (HP:0002037) | 3.34161749 |
| 42 | Gastrointestinal inflammation (HP:0004386) | 3.34021895 |
| 43 | IgG deficiency (HP:0004315) | 3.30922076 |
| 44 | Verrucae (HP:0200043) | 3.30637644 |
| 45 | Papilloma (HP:0012740) | 3.30637644 |
| 46 | Spontaneous hematomas (HP:0007420) | 3.26832867 |
| 47 | Gastrointestinal infarctions (HP:0005244) | 3.26720931 |
| 48 | Leukocytosis (HP:0001974) | 3.25615034 |
| 49 | Colitis (HP:0002583) | 3.20769084 |
| 50 | Gastrointestinal stroma tumor (HP:0100723) | 3.19798376 |
| 51 | Abnormality of B cell number (HP:0010975) | 3.19534156 |
| 52 | Recurrent bronchitis (HP:0002837) | 3.15546054 |
| 53 | Abnormality of eosinophils (HP:0001879) | 3.15469690 |
| 54 | Prolonged bleeding time (HP:0003010) | 3.10920949 |
| 55 | B lymphocytopenia (HP:0010976) | 3.06719515 |
| 56 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.06153726 |
| 57 | Urticaria (HP:0001025) | 2.96730119 |
| 58 | Hypochromic anemia (HP:0001931) | 2.96199441 |
| 59 | Combined immunodeficiency (HP:0005387) | 2.95030217 |
| 60 | Chest pain (HP:0100749) | 2.93791493 |
| 61 | Pulmonary infiltrates (HP:0002113) | 2.80231363 |
| 62 | Hypergammaglobulinemia (HP:0010702) | 2.74554561 |
| 63 | Epistaxis (HP:0000421) | 2.67362077 |
| 64 | Osteomyelitis (HP:0002754) | 2.65450868 |
| 65 | Abnormality of the fingertips (HP:0001211) | 2.64525099 |
| 66 | Recurrent sinusitis (HP:0011108) | 2.62253396 |
| 67 | Sepsis (HP:0100806) | 2.60571237 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.58552711 |
| 69 | Keratoconjunctivitis (HP:0001096) | 2.55624228 |
| 70 | Papilledema (HP:0001085) | 2.47607628 |
| 71 | Chronic diarrhea (HP:0002028) | 2.46745825 |
| 72 | Hemoptysis (HP:0002105) | 2.46027710 |
| 73 | Abnormality of the prostate (HP:0008775) | 2.39131580 |
| 74 | Gingivitis (HP:0000230) | 2.38418910 |
| 75 | Lymphoma (HP:0002665) | 2.38203561 |
| 76 | Chronic otitis media (HP:0000389) | 2.32930976 |
| 77 | Viral hepatitis (HP:0006562) | 2.30087133 |
| 78 | Petechiae (HP:0000967) | 2.22211358 |
| 79 | Skin rash (HP:0000988) | 2.21899379 |
| 80 | Gingival bleeding (HP:0000225) | 2.20853144 |
| 81 | Pulmonary embolism (HP:0002204) | 2.20690614 |
| 82 | Arterial thrombosis (HP:0004420) | 2.19109485 |
| 83 | Slow saccadic eye movements (HP:0000514) | 2.14785513 |
| 84 | Fatigue (HP:0012378) | 2.13269056 |
| 85 | IgA deficiency (HP:0002720) | 2.11477436 |
| 86 | Skin ulcer (HP:0200042) | 2.11360949 |
| 87 | Hypoplasia of the thymus (HP:0000778) | 2.11246881 |
| 88 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.10064943 |
| 89 | Basal cell carcinoma (HP:0002671) | 2.08596609 |
| 90 | Abnormality of the pleura (HP:0002103) | 2.08452993 |
| 91 | Thrombocytosis (HP:0001894) | 2.07381641 |
| 92 | Joint swelling (HP:0001386) | 2.06198134 |
| 93 | Restrictive lung disease (HP:0002091) | 2.06074035 |
| 94 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.04261667 |
| 95 | Episodic fever (HP:0001954) | 2.04202744 |
| 96 | Recurrent lower respiratory tract infections (HP:0002783) | 1.96024036 |
| 97 | Acute hepatic failure (HP:0006554) | 1.95229236 |
| 98 | Recurrent pneumonia (HP:0006532) | 1.94001742 |
| 99 | Neutropenia (HP:0001875) | 1.90952230 |
| 100 | Anorexia (HP:0002039) | 1.87975647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.16403382 |
| 2 | RIPK4 | 3.76436404 |
| 3 | PRPF4B | 3.23037731 |
| 4 | TXK | 2.55924619 |
| 5 | FES | 2.55218167 |
| 6 | TYK2 | 2.42224020 |
| 7 | GRK6 | 2.38002420 |
| 8 | BTK | 2.28699431 |
| 9 | ERN1 | 2.26058744 |
| 10 | TAOK3 | 2.23052316 |
| 11 | BLK | 2.15701555 |
| 12 | SYK | 2.13890564 |
| 13 | MAP3K14 | 2.13318207 |
| 14 | ITK | 2.04156462 |
| 15 | ZAP70 | 2.03212384 |
| 16 | KIT | 1.96544535 |
| 17 | IRAK4 | 1.95877530 |
| 18 | MAP2K3 | 1.89756304 |
| 19 | MAP3K13 | 1.85962181 |
| 20 | IKBKE | 1.79771390 |
| 21 | TNK2 | 1.77333779 |
| 22 | JAK3 | 1.75706343 |
| 23 | MAP3K10 | 1.75351140 |
| 24 | CSK | 1.73521547 |
| 25 | PASK | 1.62670492 |
| 26 | CSF1R | 1.60914979 |
| 27 | LCK | 1.58097844 |
| 28 | JAK1 | 1.54145805 |
| 29 | HCK | 1.53871673 |
| 30 | TEC | 1.52636013 |
| 31 | SIK2 | 1.46514833 |
| 32 | SIK3 | 1.44186024 |
| 33 | MARK3 | 1.43058396 |
| 34 | TBK1 | 1.42961015 |
| 35 | LYN | 1.41841789 |
| 36 | STK10 | 1.38957213 |
| 37 | CDK12 | 1.32483664 |
| 38 | IKBKB | 1.27962622 |
| 39 | TESK2 | 1.20087179 |
| 40 | TLK1 | 1.09220069 |
| 41 | MAPK12 | 1.08305919 |
| 42 | CDK4 | 1.07675413 |
| 43 | PRKCQ | 1.04809955 |
| 44 | CAMKK1 | 1.03604244 |
| 45 | SMG1 | 1.00746107 |
| 46 | PIM1 | 0.99949634 |
| 47 | BMPR2 | 0.98590421 |
| 48 | JAK2 | 0.97313065 |
| 49 | CAMKK2 | 0.94918360 |
| 50 | MAP3K11 | 0.94368397 |
| 51 | CDK19 | 0.94247761 |
| 52 | HIPK2 | 0.82804382 |
| 53 | MAPK7 | 0.80912245 |
| 54 | PDK1 | 0.80379805 |
| 55 | MAPK11 | 0.79466102 |
| 56 | NLK | 0.79017814 |
| 57 | FGR | 0.78301097 |
| 58 | TRIB3 | 0.75526195 |
| 59 | KDR | 0.71174038 |
| 60 | FGFR4 | 0.71153964 |
| 61 | FGFR3 | 0.70909451 |
| 62 | MAP2K2 | 0.69558844 |
| 63 | MAP3K1 | 0.68397026 |
| 64 | MARK2 | 0.66975191 |
| 65 | MAP3K7 | 0.66655466 |
| 66 | EPHB1 | 0.64089705 |
| 67 | LRRK2 | 0.63548010 |
| 68 | PIK3CG | 0.63376742 |
| 69 | CDK6 | 0.61631174 |
| 70 | TAOK1 | 0.53451398 |
| 71 | MATK | 0.52463135 |
| 72 | FYN | 0.52054724 |
| 73 | RET | 0.51579578 |
| 74 | MAP3K3 | 0.50838977 |
| 75 | PRKD2 | 0.50399104 |
| 76 | CDC42BPA | 0.49755067 |
| 77 | PIK3CA | 0.46457799 |
| 78 | TAOK2 | 0.45765244 |
| 79 | BRD4 | 0.44610365 |
| 80 | IRAK1 | 0.44240523 |
| 81 | MAP3K6 | 0.42782913 |
| 82 | YES1 | 0.41457951 |
| 83 | RPS6KC1 | 0.39059465 |
| 84 | RPS6KL1 | 0.39059465 |
| 85 | EEF2K | 0.36625966 |
| 86 | SIK1 | 0.36268159 |
| 87 | PRKCH | 0.36107272 |
| 88 | MELK | 0.35744333 |
| 89 | MAPK4 | 0.35468596 |
| 90 | PDPK1 | 0.34423262 |
| 91 | STK11 | 0.34323666 |
| 92 | RPS6KA6 | 0.33219964 |
| 93 | MAP2K6 | 0.31410644 |
| 94 | IRAK2 | 0.29925421 |
| 95 | SCYL2 | 0.29674596 |
| 96 | MAPK3 | 0.28609943 |
| 97 | MAPKAPK2 | 0.27817985 |
| 98 | MAP3K5 | 0.27671470 |
| 99 | CHUK | 0.26988467 |
| 100 | ABL1 | 0.24457386 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.23180560 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.31854357 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.25729164 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.13686412 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.83573048 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.60236713 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.50687296 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.49092870 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.44022024 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.43853028 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.35259743 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.26144575 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.13069745 |
| 14 | Measles_Homo sapiens_hsa05162 | 2.08616504 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.07989783 |
| 16 | Asthma_Homo sapiens_hsa05310 | 2.03228741 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.94664890 |
| 18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.93315463 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.86126646 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.83871557 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.76952891 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.74709651 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.66004976 |
| 24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.65073969 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.62952951 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.57597115 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.52817221 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.50429198 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46709177 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39760801 |
| 31 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.36054546 |
| 32 | Hepatitis B_Homo sapiens_hsa05161 | 1.34393465 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25814223 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.23906641 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.23300085 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.18546122 |
| 37 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.10587735 |
| 38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.09754033 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.08358306 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.04082026 |
| 41 | Platelet activation_Homo sapiens_hsa04611 | 1.04067989 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03681611 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.02631162 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00361696 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.95151824 |
| 46 | HTLV-I infection_Homo sapiens_hsa05166 | 0.90545325 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88917588 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 0.88355415 |
| 49 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.87379297 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 0.86235972 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81089847 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 0.80860205 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79491855 |
| 54 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.78990493 |
| 55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78971850 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78135260 |
| 57 | Colorectal cancer_Homo sapiens_hsa05210 | 0.72588407 |
| 58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72015132 |
| 59 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68227175 |
| 60 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66746708 |
| 61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63040574 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61382695 |
| 63 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60731005 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60127298 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56928934 |
| 66 | Pertussis_Homo sapiens_hsa05133 | 0.56385498 |
| 67 | Phagosome_Homo sapiens_hsa04145 | 0.56225703 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56219087 |
| 69 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55640037 |
| 70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53996446 |
| 71 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51894429 |
| 72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50678419 |
| 73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50433449 |
| 74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50355825 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49472571 |
| 76 | Prostate cancer_Homo sapiens_hsa05215 | 0.43705373 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43509523 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.39202217 |
| 79 | Salmonella infection_Homo sapiens_hsa05132 | 0.38436613 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37825663 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37529024 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.37309874 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32844174 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32739762 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31733792 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31249127 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28629366 |
| 88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.28107683 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28050794 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26745935 |
| 91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.25220092 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24797429 |
| 93 | Glioma_Homo sapiens_hsa05214 | 0.24259791 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.24036596 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.21926436 |
| 96 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.20234380 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20035896 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.17984165 |
| 99 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.17814767 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.17166204 |

